Pfizer applies for full FDA approval of its two-dose Covid vaccine

Pfizer is applying for full FDA approval of its two-dose Covid-19 vaccine, which would give the vaccine rollout a major boost nationwide. NBC News medical contributor Dr. Natalie Azar joins News NOW to explain the approval process and how full FDA approval could impact vaccine confidence.